OPRM1 and hepatocellular carcinoma: Recent studies have also linked MOR overexpression to hepatocellular carcinoma (HCC) progression and poor prognosis in HCC patients, while MOR silencing is found to reduce HCC-associated tumorigenesis (Chen et al., 2019; Li et al., 2019).